secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001493152-26-016486
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CyPath® Lung case study shows test helped defer biopsy for high-risk patient with 30mm nodule
--------------------------------------------------------------------------------

- 70-year-old female, 50 pack-year smoking history, 30mm lung nodule with high cancer risk by imaging and models.
- CyPath® Lung returned negative result ('Unlikely Malignancy'); follow-up CT showed nodule had completely resolved.
- Treating pulmonologist credited CyPath® Lung for prompting additional imaging before scheduled biopsy.
- CyPath® Lung demonstrated 92% sensitivity, 87% specificity, and 88% accuracy in detecting lung cancer in small nodules in clinical trial.
- Case illustrates potential to avoid risky, unnecessary procedures in patients with comorbidities like emphysema.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226016486/0001493152-26-016486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226016486/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-016486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer